- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Recombinant fusion protein consisting of the extracellular p
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule
| EU orphan designation number: | EU/3/06/411
|
| Active ingredient: | Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule |
| Indication: | Prevention of Graft-versus-Host disease |
| Sponsor: | Apogenix GmbH
Im Neuenheimer Feld 584, D-69120 Heidelberg, Deutschland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 06/11/2006 | Orphan designation | EMEA/OD/054/06 | (2006)5352 of 31/10/2006 |
CONTACT
EU links
Directorate General Health & Consumers